
    
      Patient enrollment and data acquisition is to be carried out on a prospective basis. It is
      planned to enroll a total of 50 patients with advanced heterogeneous emphysema. After
      decision to undertake endoscopic lung volume reduction by valve implantation patients will be
      randomised to two treatment arms. 25 patients receive unilateral IBV treatment or unilateral
      EBV treatment in each case. All patients will undergo treatment at one study centre in
      Heidelberg.
    
  